Journal of International Oncology››2020,Vol. 47››Issue (1): 18-23.doi:10.3760/cma.j.issn.1673-422X.2020.01.003
• Original Articles •Previous ArticlesNext Articles
Li Ranran1,2, Yang Fuguo1(), Fan Min2, Huang Wei2, Yuan Fang2
Received:
2019-11-18Revised:
2019-12-13Online:
2020-01-08Published:
2020-03-22Contact:
Yang Fuguo E-mail:yfuguo@126.comSupported by:
Li Ranran, Yang Fuguo, Fan Min, Huang Wei, Yuan Fang. Effect of perception control and self-management on cancer-related fatigue in breast cancer patients with chemotherapy[J]. Journal of International Oncology, 2020, 47(1): 18-23.
"
项目 | 例(%) | 评分(
|
t/F值 | P值 | |||
---|---|---|---|---|---|---|---|
年龄(岁) | |||||||
18~30 | 23(9.3) | 5.22±0.76 | |||||
31~40 | 71(28.9) | 5.13±0.71 | |||||
41~50 | 80(32.5) | 5.11±0.76 | 0.250 | 0.910 | |||
51~60 | 60(24.4) | 5.20±0.65 | |||||
>60 | 12(4.9) | 5.08±0.82 | |||||
民族 | |||||||
汉族 | 231(93.9) | 5.15±0.72 | 0.216 | 0.829 | |||
其他 | 15(6.1) | 5.11±0.64 | |||||
婚姻状况 | |||||||
未婚 | 17(6.9) | 5.18±0.70 | |||||
已婚 | 186(75.6) | 5.18±0.72 | 0.940 | 0.392 | |||
离异或丧偶 | 43(17.5) | 5.01±0.70 | |||||
文化程度 | |||||||
小学 | 20(8.1) | 5.40±0.62a | |||||
初中 | 78(31.7) | 5.23±0.72a | 3.392 | 0.019 | |||
高中/中专 | 96(39.0) | 4.98±0.67 | |||||
大学及以上 | 52(21.1) | 5.25±0.78a | |||||
居住地区 | |||||||
城市 | 145(58.9) | 5.08±0.70 | 1.890 | 0.060 | |||
农村 | 101(41.1) | 5.25±0.74 | |||||
职业 | |||||||
工人 | 29(11.8) | 5.05±0.56 | |||||
农民 | 54(22.0) | 5.19±0.80 | |||||
公务员 | 11(4.5) | 5.47±0.90 | 1.792 | 0.115 | |||
职工 | 80(32.5) | 5.19±0.72 | |||||
自由择业者 | 54(22.0) | 5.16±0.67 | |||||
退休 | 18(7.3) | 4.75±0.66 | |||||
医疗费用来源 | |||||||
自费 | 8(3.3) | 5.81±0.54b | |||||
职工医保 | 76(30.9) | 5.17±0.63bc | 4.368 | 0.005 | |||
居民医保 | 113(45.9) | 5.20±0.78bc | |||||
商业保险(含同时 载有居民/职工医保) |
49(19.9) | 4.86±0.65 | |||||
家庭月收入(元) | |||||||
≤1 000 | 3(1.2) | 5.51±0.37 | |||||
1 001~3 000 | 63(25.6) | 5.07±0.70 | 1.904 | 0.130 | |||
3 001~6 000 | 111(45.1) | 5.08±0.73 | |||||
>6 000 | 69(28.0) | 5.30±0.71 | |||||
病理类型 | |||||||
浸润性导管癌 | 225(91.5) | 5.13±0.73 | -0.604 | 0.546 | |||
非浸润性导管癌 | 21(8.5) | 5.24±0.61 | |||||
项目 | 例(%) | 评分(
|
t/F值 | P值 | |||
疾病分期 | |||||||
Ⅰ期 | 10(4.1) | 4.82±0.65d | |||||
Ⅱ期 | 57(23.2) | 5.92±0.71de | 4.376 | 0.005 | |||
Ⅲ期 | 106(43.1) | 5.17±0.70 | |||||
Ⅳ期 | 73(29.7) | 5.33±0.72 | |||||
化疗方案 | |||||||
AC-T(H)或TAC(H) | 136(55.3) | 5.11±0.75 | |||||
TC(H) | 24(9.8) | 5.33±0.60 | 0.810 | 0.490 | |||
TX或NP | 74(30.1) | 5.13±0.71 | |||||
其他 | 12(4.9) | 5.30±0.63 | |||||
化疗周期 | |||||||
1周期 | 24(9.8) | 4.93±0.60fg | |||||
2~3周期 | 38(15.4) | 5.41±0.73 | 3.865 | 0.010 | |||
4~5周期 | 76(30.9) | 5.29±0.65 | |||||
≥6周期 | 108(43.9) | 5.00±0.74fg | |||||
病程 | |||||||
≤1年 | 98(39.8) | 5.09±0.78h | |||||
>1年且≤3年 | 36(14.6) | 4.95±0.61h | 3.094 | 0.028 | |||
>3年且≤5年 | 52(21.1) | 5.38±0.63 | |||||
>5年 | 60(24.4) | 5.16±0.70 |
"
项目 | 各维度评分 | 各条目评分 | F值 | P值 |
---|---|---|---|---|
癌症经验 | 59.85±7.10 | 3.74±0.44 | ||
个人经验 | 15.30±2.43 | 3.83±0.61a | ||
社会经验 | 23.18±3.16 | 3.86±0.53a | 7.248 | 0.001 |
情绪经验 | 22.03±3.72 | 3.67±0.62 | ||
控制效能 | 47.25±4.79 | 3.63±0.37 | ||
个人效能 | 16.70±2.72 | 3.34±0.54bc | ||
集体效能 | 18.57±2.22 | 3.71±0.44c | 96.595 | <0.001 |
医护效能 | 12.00±1.73 | 4.00±0.58b | ||
自我管理 | 152.26±6.67 | 3.46±0.15 | ||
日常生活管理 | 35.63±3.76 | 3.24±0.34defg | ||
症状管理 | 25.45±2.93 | 3.64±0.42egh | ||
情绪管理 | 29.29±3.90 | 3.25±0.43efg | 65.009 | <0.001 |
与医护人员沟通 | 15.53±2.42 | 3.88±0.61eg | ||
信息管理 | 11.07±1.98 | 3.69±0.66g | ||
自我管理效能感 | 35.29±4.24 | 3.53±0.42 | ||
CRF | 5.14±0.72 | 5.14±0.72 | ||
行为/严重维度 | 6.00±0.79 | 6.00±0.79ijk | ||
情感维度 | 4.62±1.14 | 4.62±1.14jk | 130.973 | <0.001 |
感知维度 | 5.42±0.87 | 5.42±0.87k | ||
认知维度 | 4.55±0.96 | 4.55±0.96 |
"
项目 | B值 | SE值 | β值 | t值 | P值 |
---|---|---|---|---|---|
(常量) | 11.748 | 1.006 | - | 11.676 | <0.001 |
文化程度(小学) | 0.164 | 0.130 | 0.063 | 1.259 | 0.209 |
文化程度(初中) | -0.034 | 0.091 | -0.022 | -0.372 | 0.710 |
文化程度(高中/中专) | -0.113 | 0.087 | -0.077 | -1.297 | 0.196 |
居住地(城市) | -0.013 | 0.066 | -0.009 | -0.194 | 0.846 |
医疗费用来源(自费) | 0.595 | 0.194 | 0.147 | 3.069 | 0.002 |
医疗费用来源(职工医保) | 0.063 | 0.096 | 0.040 | 0.655 | 0.513 |
医疗费用来源(居民医保) | 0.087 | 0.094 | 0.061 | 0.933 | 0.352 |
疾病分期(Ⅱ期) | -0.055 | 0.182 | -0.032 | -0.301 | 0.764 |
疾病分期(Ⅲ期) | 0.039 | 0.170 | 0.027 | 0.231 | 0.818 |
疾病分期(Ⅳ期) | 0.042 | 0.173 | 0.027 | 0.243 | 0.809 |
化疗周期(1周期) | 0.190 | 0.114 | 0.079 | 1.667 | 0.097 |
化疗周期(2~3周期) | 0.232 | 0.096 | 0.117 | 2.423 | 0.016 |
化疗周期(4~5周期) | 0.241 | 0.073 | 0.157 | 3.323 | 0.001 |
病程(>1年且≤3年) | -0.160 | 0.097 | -0.079 | -1.647 | 0.101 |
病程(>3年且≤5年) | 0.033 | 0.093 | 0.019 | 0.357 | 0.722 |
病程(>5年) | -0.089 | 0.089 | -0.054 | -1.005 | 0.316 |
癌症经验 | 0.026 | 0.005 | 0.254 | 5.318 | <0.001 |
控制效能 | -0.045 | 0.007 | -0.300 | -6.203 | <0.001 |
自我管理 | -0.039 | 0.005 | -0.366 | -7.450 | <0.001 |
[1] | 林红, 张鑫, 刘蕾 . 乳腺癌癌因性疲乏护理现状及进展[J]. 沈阳医学院学报, 2012,14(04):244-245. DOI: 10.3969/j.issn.1008-2344.2012.04.022. |
[2] | Berger AM, Mooney K, Alvarez-Perez A , et al. Cancer-related fatigue, version 2.2015[J]. J Natl Compr Canc Netw, 2015,13(8):1012-1039. DOI: 10.6004/jnccn.2015.0122. |
[3] | 杨军, 李新霞, 张爱华 . 乳腺癌患者自我管理行为与癌性疲乏及生存质量的相关研究[J]. 护士进修杂志, 2017,32(2):99-102. DOI: 10.16821/j.cnki.hsjx.2017.02.002. |
[4] | 高伟娟 . 控制感的心理学理解——控制感研究述评[D]. 长春: 吉林大学, 2005. |
[5] | Hou WK . Intrapersonal and interpersonal dimensions of cancer perception: a confirmatory factor analysis of the cancer experience and efficacy scale (CEES)[J]. Support Care Cancer, 2010,18(5):561-571. DOI: 10.1007/s00520-009-0687-2. |
[6] | 程玲灵 . 癌症患者自我管理测评量表的构建及信效度检验[D]. 唐山: 华北理工大学, 2017. |
[7] | 叶艳胜, 鲍翠玉, 李莉 . 低年资护士生涯适应力与时间管理倾向的关系研究[J]. 护理学杂志, 2015,30(5):69-70, 83. DOI: 10.3870/hlxzz.2015.05.069. |
[8] | 谭杏, 黄丽芳, 孙彩霞 , 等. 肺癌化疗患者感知控制水平现状调查及影响因素分析[J]. 中国实用护理杂志, 2016,32(29):2258-2262. DOI: 10.3760/cma.j.issn.1672-7088.2016.29.005. |
[9] | So WK, Dodgson J, Tai JW . Fatigue and quality of life among Chinese patients with hematologic malignancy after bone marrow transplantation[J]. Cancer Nurs, 2003, 26(3): 211-219, quiz 220-221. DOI: 10.1097/00002820-200306000-00006. |
[10] | 刘芳, 姜文彬, 闫琪 , 等. 乳腺癌术后辅助化疗患者癌因性疲乏与社会支持相关性的研究[J]. 护理管理杂志, 2013,13(4):235-237. DOI: 10.3969/j.issn.1671-315X.2013.04.003. |
[11] | 王梅芳, 姚晚侠 . 康复期乳腺癌癌因性疲乏及影响因素的纵向研究[J]. 中国实用护理杂志, 2017,33(9):651-657. DOI: 10.3760/cma.j.issn.1672-7088.2017.09.003. |
[12] | 何明珠 . 肿瘤化疗患者癌因性疲乏状况及其影响因素的研究[D]. 石河子市: 石河子大学, 2015. |
[13] | 杜富秀 . 乳腺癌术后辅助化疗患者癌因性疲乏及影响因素的研究[D]. 北京: 中国协和医科大学, 2007. |
[14] | 张毅 . 第41届美国圣安东尼奥乳腺癌研讨会重要研究进展解析[J]. 中华乳腺病杂志(电子版), 2019,13(3):129-136. DOI: 10.3877/cma.j.issn.1674-0807.2019.03.001. |
[15] | 陈树珍 . 稳定期慢性阻塞性肺疾病患者认知功能水平和影响因素分析及护理干预措施[J]. 护理实践与研究, 2019,16(20):57-59. DOI: 10.3969/j.issn.1672-9676.2019.20.022. |
[16] | 张丽娣, 李乐之 . 慢性病感知控制研究现状及展望[J]. 中华护理杂志, 2014,49(1):91-94. DOI: 10.3761/j.issn.0254-1769.2014.01.023. |
[17] | 马波, 王海丽, 李波 . 乳腺癌患者自我感受负担与自我管理行为的相关性研究[J]. 中国美容整形外科杂志, 2016,27(3):191-192. DOI: 10.3969/j.issn.1673-7040.2016.03.024. |
[18] | 韦燕萍, 高铭云, 吴庆珍 . 恶性肿瘤患者自我管理的研究现状及进展[J]. 护理实践与研究, 2016,13(2):31-33. DOI: 10.3969/j.issn.1672-9676.2016.02.014. |
[1] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[2] | Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[3] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[4] | Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[5] | Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer: present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58. |
[6] | Wang Jing, Xu Wenting.Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[7] | Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531. |
[8] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[9] | Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462. |
[10] | Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356. |
[11] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[12] | Zhu Jun, Huang Meijin, Li Yuan, Liu Zegang, Xun Xin, Chen Hong.Research progress on targeted therapy of breast cancer with low expression of HER2[J]. Journal of International Oncology, 2023, 50(4): 236-240. |
[13] | Zhou Ting, Xu Shaohua, Mei Lin.Efficacy and safety of bevacizumab combined with capecitabine in the treatment of advanced breast cancer[J]. Journal of International Oncology, 2023, 50(3): 144-149. |
[14] | Li Lixi, Zhang Di, Luo Yang, Ma Fei.Clinical application of PARP inhibitors in breast cancer[J]. Journal of International Oncology, 2023, 50(2): 91-96. |
[15] | Geng Rui, Ma Junqiang, Guo Qiang, Niu Zhaofeng.Tendency of elderly patients with breast cancer to choose comprehensive treatment mode and its influencing factors[J]. Journal of International Oncology, 2023, 50(11): 650-654. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||